Documentation of HBOC or Lynch-associated "pathogenic/ likely pathogenic" mutation per American College of Medical Genetics and Genomics criteria (1)

Diagnosis of one or more invasive cancers: epithelial ovarian, fallopian tube, primary peritoneal, breast, colorectal, endometrial

Mutation listed in NCCN guidelines with at least Category 2A evidence for intervention

Over the age of 18

Psychological ability and general health that permits completion of study requirements and follow-up

Willingness to complete follow-up surveys in person, electronically, or by telephone for up to 6 months

Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome